It’s no secret that the life sciences sector has fueled demand for Big Law firms even as the legal sector grappled with the initial shock of the pandemic. This work is particularly core to Cooley, where the life sciences sector touches a third of the firm’s $1.5 billion in annual revenue, with 95% of its attorneys serving life sciences clients.

“If you took the life sciences group out of the firm, it would be its own Am Law 100 firm,” Christian Plaza, vice chairman of the firm’s global life sciences group, said.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]